Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Careers

Chinese Firm Halts U.S. Plant Project

by Rick Mullin
March 30, 2015 | A version of this story appeared in Volume 93, Issue 13

UniTao, the Chinese company that bought a Boehringer Ingelheim pharmaceutical chemicals plant in Petersburg, Va., last November says it has decided not to reopen the facility “until business conditions improve.” The little-known company paid $22.5 million for the plant, which employed about 240 people when Boehringer closed it in 2013. At the time, Unitao said former Boehringer workers would be “first in line” for positions at a reopened plant. Now the firm says it will keep only a small team on site. It won’t accept local and state economic development grants for job creation.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.